Certis Biologicals Revenue and Competitors

Columbia, MD USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Certis Biologicals's estimated annual revenue is currently $27.4M per year.(i)
  • Certis Biologicals's estimated revenue per employee is $155,000

Employee Data

  • Certis Biologicals has 177 Employees.(i)
  • Certis Biologicals grew their employee count by 4% last year.

Certis Biologicals's People

NameTitleEmail/Phone
1
Global VP MarketingReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
VP Business Development and LicensingReveal Email/Phone
4
VP -Latin AmericaReveal Email/Phone
5
VP Research And DevelopmentReveal Email/Phone
6
EVP and International SalesReveal Email/Phone
7
EVP Corporate Development and ComplianceReveal Email/Phone
8
Head International BusinessReveal Email/Phone
9
Director Business DevelopmentReveal Email/Phone
10
Chief Administrative Officer (CAO)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Certis Biologicals?

Certis Biologicals is a pioneer in the development of biological pesticides and has become one of the world’s leading manufacturers and distributors of biopesticides. We specialize in: Biological product development, from screening to formulation to field development Manufacturing: fermentation and formulation Global registrations for biological products Global sales channels. We export to more than 30 countries. Certis Biologicals traces its roots to some of the early leaders in the development of biological and botanical pesticides, beginning with the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. Since then, the company has grown by identifying and acquiring products that complement its product line. These include baculovirus products acquired from Biosys in 1997 and Bt bioinsecticide products acquired from Novartis in 1997 and Ecogen in 2002. In 2001, Mitsui & Co., a leading Japanese trading company, acquired Thermo Trilogy and renamed it Certis U.S.A. L.L.C. Within Mitsui's AgriScience Division, Certis Biologicals is positioned as the global competence center for biological control technologies. Today the company’s product line represents some of finest bioproducts and active ingredients in the industry.

keywords:N/A

N/A

Total Funding

177

Number of Employees

$27.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M1779%N/A
#2
$3.5M1778%N/A
#3
$300M178-1%$95M
#4
$30.3M179-14%N/A
#5
$66M1833%N/A